The Commercialization of Umbilical Cord Blood Banking in China and its Operational Challenges

Albert Chen of China Cord Blood Corporation  joined us last year at Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘The Commercialization of Umbilical Cord Blood Banking in China and its Operational Challenges .’ Download his presentation now in order to understand more about: CCBC Overview Regulatory Overview Sales and Marketing Operational Challenges …and much more! Get your copy here!  …

Guest Blog: Cord blood – A real lifeline?

Another first for Terrapinn this year was the parallel Cord Blood World Europe Congress running alongside the Stem Cell and Regenerative Medicine Congress at the Business Design Centre in London, far too enticing a proposition not to pop in and take a look. Some ten years ago (or perhaps slightly more) I stood in a GMP suite staring at my …

New uses for Cord Blood as an immunotherapy - will be covered at the Cord Blood World Europe Congress, 20-21 May in London at the Business Design Centre

New uses for Cord Blood as an immunotherapy and in the treatment of lysosomal storage disease

Dr Jaap Boelens, Pediatric Oncologist at the University of Utrecht has also been working on developing multiple treatments using cord blood. One of which involves using cord blood transplants to improve the outcomes of an immunotherapy (Dendritic Cell Vaccination) which will go into the clinic later this year. He will be discussing his findings at the Cord Blood World Europe Congress in …

Cord Blood Market Infographic in support of the Cord Blood World Europe Congress 2015

Cord Blood Market News: The 4 key metrics

  If you’re managing a cord blood bank or investing in the cord blood market, the market can initially appear technical and confusing. However, if you focus on four key metrics, you can quickly assess the technical attributes that matter. These metrics include: Hematopoietic Stem Cells Transplant Rates  – Determine the number of hematopoietic stem cell transplants occurring per year …

Private Cord Blood Banks vs Public Health: Is it Time to Bury the Hatchet?

Can private cord blood banks ever work in synergy with public and national health services? Cord blood is the blood that remains in the placenta and umbilical cord after a baby is born. It is rich in stem cells, which can help to cure many life threatening diseases. The stem cells found in cord blood restore the function of the …

Stem Cells Regenerative Medicine Congress is where experts like DaVinci Biosciences gather to network, learn from each other, and discuss the latest stem cell developments.

DaVinci Biosciences on the Isolation and Characterization of Umbilical Cord Lining Stem Cells

Stem cells have been isolated from all developmental periods of life and are thought to participate in tissue regeneration/repair. Hematopoietic stem cells (HSCs) isolated from bone marrow has been used for years in order to reconstitute the bone marrow of recipients suffering from hematological disorders. Since its initial clinical use 20 years ago, umbilical cord blood (UCB) has been considered …

The World Cord Blood Congress is where experts like Tissue Regeneration Therapeutics's John Davies come to network, learn from each other, and discuss the latest cord blood strategies and technology.

Tissue Regeneration Therapeutics on Perivascular Tissue

John Davies, President and Chief Executive Officer of Tissue Regeneration Therapeutics, presented at the World Cord Blood Congress 2013 on the topic, ‘Perivascular tissue: the source of MSCs in the human umbilical cord.’ John Davies presented during the conference segment focused on cold chain & engraftment efficiency. Other speakers who presented on similar topics included Cryo-Cell’s Chief Scientific Officer Linda …